Johnson Investment Counsel’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,618
Closed -$249K 678
2023
Q1
$249K Hold
4,618
﹤0.01% 586
2022
Q4
$243K Sell
4,618
-250
-5% -$12.7K ﹤0.01% 593
2022
Q3
$230K Buy
+4,868
New +$253K ﹤0.01% 578

Other funds holding IHI

Johnson Investment Counsel's IHI Position: Q2 2023 in Review

Johnson Investment Counsel sold out of iShares US Medical Devices ETF (IHI) in Q2 2023, closing a stake of 4,618 shares — an estimated $249K sold.

Johnson Investment Counsel first reported a position in IHI in Q3 2022 and held it in 3 quarters. The position peaked at $249K in Q1 2023. 585 funds tracked by Wall St. Rank hold IHI as of Q2 2023.

  • Johnson Investment Counsel reported no remaining iShares US Medical Devices ETF position as of Q2 2023 after selling out during the quarter.
  • Johnson Investment Counsel sold 4,618 iShares US Medical Devices ETF shares in Q2 2023, an estimated $249K.
  • Johnson Investment Counsel first reported a position in iShares US Medical Devices ETF in Q3 2022 and held it in 3 quarters.
  • Johnson Investment Counsel's iShares US Medical Devices ETF position peaked at $249K in Q1 2023.
  • 585 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2023.

Based on Johnson Investment Counsel's 13F filing for Q2 2023, filed 10 Aug 2023.